Clinical trial · Observational
Registry for Pancreatic Cancer
Registry to Evaluate Multi-modality Therapies for Pancreatic Cancer
NCT03001505CI-TRIAL-00030689withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study design changed to clinical database only with no research question to be studied.
Summary
Brief summary (as posted)
This is an observational, prospective and retrospective registry of patients with pancreatic cancer treated in Duke University Health System, which will examine patient and treatment effects on cancer outcomes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Patients with pancreatic cancer
- description
- Patients diagnosed with pancreatic cancer evaluated at this institution.
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 10 years
- description
- Survival from Diagnosis to time of death
Secondary outcomes (3)
- measure
- Disease-free survival
- timeFrame
- 10 years
- description
- length of time with no evidence of disease
- measure
- Metastasis
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Pancreatic cancer Exclusion Criteria: * Younger than 18 years of age
References
Publications (0)
Data not yet available
No reference posted for this study.